Form 4: Lam Research Executive Sells Shares Under 10b5-1 Trading Plan

Sentiment:

SEC Form 4


Seshasayee Varadarajan, a Senior Vice President at Lam Research, executed stock option exercises and sales under a pre-arranged 10b5-1 trading plan.

Summary

  • On February 20, 2025, Seshasayee Varadarajan, a Senior Vice President at Lam Research, engaged in transactions involving Lam Research common stock.
  • Varadarajan exercised options to acquire 35,760 shares at $19.007 and sold them at $90 per share.
  • He also exercised options to acquire 74,320 shares at $17.675 and sold them at $90 per share.
  • These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 29, 2024.
  • Following these transactions, Varadarajan directly owns 179,084 shares of Lam Research common stock.
  • Additionally, he indirectly owns 2,366.994 shares through a 401(k) plan.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing simply reports stock transactions by an executive under a pre-existing trading plan. There's no inherent positive or negative signal.

Positives

  • The transactions were executed under a pre-arranged 10b5-1 trading plan, which can mitigate concerns about insider trading.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies like Lam Research. Monitoring these transactions can provide insights into management's perspective on the company's valuation and future prospects. The use of 10b5-1 plans is a standard practice to allow insiders to sell shares while avoiding accusations of trading on non-public information.

Comparison to Industry Standards

  • Executive compensation packages at companies like Applied Materials (AMAT) and ASML Holding (ASML) often include stock options and restricted stock units.
  • The use of 10b5-1 trading plans is a common practice among executives at these and other publicly traded companies to manage their stock holdings and avoid insider trading concerns.
  • The reported transactions are typical for executives managing their personal finances and diversifying their investment portfolios.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders due to the increased supply of shares in the market, but the effect is likely minimal given the trading plan.

Key Dates

DateDescription
05/29/2024Date the reporting person adopted the Rule 10b5-1 trading plan
02/20/2025Date of the transactions: stock option exercises and sales
02/21/2025Date of signature for the Form 4 filing
03/01/2025Date when some stock options become exercisable
03/01/2026Date when some stock options become exercisable

Keywords

Lam Research, LRCX, Seshasayee Varadarajan, stock options, Form 4, insider trading, 10b5-1 plan, securities, equity

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.